Invention Grant
- Patent Title: Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
-
Application No.: US15115440Application Date: 2014-07-04
-
Publication No.: US10174010B2Publication Date: 2019-01-08
- Inventor: Xiaoxia Sheng , Xiaohong Sheng , Kun Zhao , Xiaoye Song
- Applicant: Hangzhou Pushai Pharmaceutical Technology Co., Ltd.
- Applicant Address: CN Hangzhou
- Assignee: HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO., LTD.
- Current Assignee: HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO., LTD.
- Current Assignee Address: CN Hangzhou
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: CN201410106768 20140319
- International Application: PCT/CN2014/081656 WO 20140704
- International Announcement: WO2015/139386 WO 20150924
- Main IPC: C07D409/10
- IPC: C07D409/10 ; A61K31/7042 ; A61K9/00 ; A61K9/10 ; A61K9/16 ; A61K9/20 ; A61K9/28 ; A61K9/48 ; A61K31/381 ; A61K47/12 ; A61K47/14 ; A61K47/36
Abstract:
The present invention relates to canagliflozin Monohydrate and its crystalline forms, which as compared to the prior art, have higher stability in water or aqueous system, are more suitable for wet granulation processes or suspension preparations and have good storage stability; the present invention also relates to preparation methods of canagliflozin Monohydrate and its crystalline forms, pharmaceutical compositions thereof and uses thereof in preparation of drugs for treating diseases such as diabetes, diabetes complications, obesity and so on.
Public/Granted literature
- US20170145000A1 CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF Public/Granted day:2017-05-25
Information query
